Clinical Trial

Safety and Efficacy of FETO in CDH Phase III

Study acronym: CDH FETO
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses and standard of care control group
Trial Details
NCT Number NCT07187206
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Conditions Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia, Pulmonary Hypertension
Enrollment 75 participants
Start Date 2025-09-30
Primary Completion 2032-12-01 (estimated)
Study Completion 2033-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-22